Intratumoral habitat imaging for progression-free survival prediction of patients with high-risk, non-metastatic clear cell renal cell carcinoma
- 16 May 2026
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (11) , 1-12
Abstract
Purpose Accurate risk stratification for patients with high-risk, non-metastatic clear cell renal cell carcinoma (ccRCC) remains a clinical challenge. Our aim is to develop and validate an imaging model based on intratumoral habitat imaging for non-invasive assessment of progression-free survival (PFS) in this high-interest population. Methods A retrospective analysis was performed on a cohort of 220 patients with ccRCC from three hospitals. Preoperative CT images and clinical data were comprehensively analyzed. K-mean clustering method was used to generate habitat subregions using contrast-enhanced CT images. Radiomic features were extracted from habitat subregions and the entire tumor, Random Survival Forest for PFS prediction were constructed using conventional radiomics features, habitat subregions-derived radiomics. Model evaluation included calibration curve, receiver operating characteristic curve (ROC) and Kaplan-Meier survival analysis. Results The Habitat 3 model demonstrated favorable prognostic performance. In the training cohort, 1-, 3-, and 5-year AUCs were 0.92, 0.92, and 0.78, respectively. In the external test set, the model maintained robustness with 1-, 3-, and 5-year AUCs of 0.87, 0.74, and 0.94, outperforming traditional radiomics and other Habitat models. Furthermore, patients stratified by Habitat 3 showed significant survival differences between high-risk and low-risk groups in both cohorts. Conclusion We proposed a habitat-based imaging technique for the preliminary analysis of high-risk ccRCC. This retrospective study suggests that habitat signatures are associated with PFS, serving as a potential non-invasive complement to provide insights into tumor heterogeneity.Keywords
Funding Information
- General Project of Hangzhou Health Science and Technology Program (Grant No.B20253445)
- Zhejiang Provincial Natural Science Foundation of China (Grant No. LTGY24H180003)
This publication has 26 references indexed in Scilit:
- Risk stratification for recurrence after nephrectomy in high-risk renal cell carcinoma patientsInternational Journal of Clinical Oncology, 2025
- Development and validation of a clinic-radiomics model based on intratumoral habitat imaging for progression-free survival prediction of patients with clear cell renal cell carcinoma: A multicenter studyUrologic Oncology: Seminars and Original Investigations, 2024
- Sub-regional Radiomics Analysis for Predicting Metastasis Risk in Clear Cell Renal Cell Carcinoma: A Multicenter Retrospective StudyAcademic Radiology, 2024
- The radiomics-based tumor heterogeneity adds incremental value to the existing prognostic models for predicting outcome in localized clear cell renal cell carcinoma: a multicenter studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors?Current Problems in Cancer, 2021
- Artificial intelligence in tumor subregion analysis based on medical imaging: A reviewJournal of Applied Clinical Medical Physics, 2021
- Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell CarcinomaEuropean Urology Oncology, 2021
- Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With SurvivalJAMA Network Open, 2021
- Clustering of multi-parametric functional imaging to identify high-risk subvolumes in non-small cell lung cancerRadiotherapy and Oncology, 2017
- Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary PatientsEuropean Urology, 2017